Histogen Reports First Quarter 2021 Earnings and Provides Business Update
Retrieved on:
Thursday, May 13, 2021
We also welcomed Dr. Susan Windham-Bannister and Rochelle Fuhrmann to our Board of Directors.
Key Points:
- We also welcomed Dr. Susan Windham-Bannister and Rochelle Fuhrmann to our Board of Directors.
- Both Sue and Rochelle bring to our board relevant industry experience with respective expertise in strategic growth and financial management, which will serve Histogen well.
- We anticipate enrollment to commence in the second quarter of 2021.
- Ms. Fuhrmann currently serves as the Vice President Audit and Enterprise Risk Management at Becton Dickinson (BD).